W. Patton

发表

Identification of a Circulating Soluble Form of CD80: Levels in Patients with Hematological Malignancies

B. Hock, J. McKenzie, G. Starling, 2004, Leukemia & lymphoma.

The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome

E. Estey, Yu Shen, M. Albitar, 2003, Cancer.

An open-label, single-arm, phase 1 study to assess biomarker effects, efficacy and safety of ofatumumab in patients with refractory chronic lymphocytic leukemia

T. Kipps, R. Lindeman, G. Chan, 2015, Leukemia & lymphoma.

Iron chelation therapy in myelodysplastic syndromes: we need more evidence, not more guidelines

W. Patton, A. Butler, 2012, Internal medicine journal.

Successful high dose therapy for relapsed mediastinal large B cell lymphoma following surgical repair of anterior chest wall defect.

K. Bayston, J. Hanley, D. Hart, 2000, Clinical and laboratory haematology.

Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation.

E. Kimby, N. Schmitz, H. Tilly, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Co-incidental presentation of IgA lambda multiple myeloma and pleural involvement with IgM kappa non-Hodgkin's lymphoma.

W. Patton, R. Manley, J. Monteath, 1999, Clinical and laboratory haematology.

Dendritic cells in chronic myelomonocytic leukaemia

D. Hart, S. Gunningham, D. Hart, 1999, British journal of haematology.

Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma.

B. Chapman, S. Chambers, M. Drummond, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

The soluble form of CD83 is present at elevated levels in a number of hematological malignancies.

A. Steinkasserer, B. Hock, J. McKenzie, 2004, Leukemia research.

Graft Transit Time Has No Effect on Outcome of Unrelated Donor Hematopoietic Cell Transplants Performed in Australia and New Zealand: A Study from the Australasian Bone Marrow Transplant Recipient Registry.

J. Szer, D. Ma, H. Blacklock, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Mixed lymphocyte reactions do not predict severity of graft versus host disease (GVHD) in HLA-DR compatible, sibling bone marrow transplants.

Wayne F. Patton, T. Gentle, M. Baynham, 1988, Journal of clinical pathology.

Spin density projection‐assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia

D. Taylor, T. S. St. Pierre, W. Patton, 2012, Internal medicine journal.

A second case of Corynebacterium pseudotuberculosis in New Zealand.

M. Schousboe, S. Chambers, W. Lester, 1997, The New Zealand medical journal.

Circulating levels and clinical significance of soluble CD86 in myeloma patients

M. Drayson, J. McKenzie, W. Patton, 2006, British journal of haematology.

Multiply resistant Salmonella typhimurium septicaemia in an immunocompromised patient successfully treated with ciprofloxacin.

M. Leyland, A. Geddes, W. Patton, 1985, The Journal of antimicrobial chemotherapy.

Acquired myeloma-associated Type III hyperlipidaemia treated by nonmyeloablative HLA-identical sibling allogeneic stem cell transplant using a donor with essential thrombocythaemia (ET): evidence of engraftment without manifestation of ET in recipient

C. Florkowski, W. Patton, V. Hanrahan, 2005, Bone Marrow Transplantation.

Polyploidy in myelodysplastic syndrome: a case report.

W. Patton, J. Cochrane, R. Manley, 1998, Cancer genetics and cytogenetics.